CERUS CORP (CERS) research

CERUS CORP
ShareXLinkedInReddit
Sector
Health Care
Last price
$2.65
As of

CERUS CORP (CERS): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-07-30.

As of . Source: SEC EDGAR filings for CERS. Method and limitations.

SHARE THIS CARD

Share the CERS intelligence card

A branded snapshot of CERS: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion CERS intelligence card preview
Post to X
LIVE TERMINAL

See CERS live in the terminal

Track CERS's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live CERS terminal, free

Active signals for CERS

FREE, NO ACCOUNT

Every signal on CERS, as it fires

You are seeing 5 of 20 signals recorded on CERS since 2026-05-24.

The five above all landed on 2026-09-06. The other 15 were recorded on 4 other days. 15 of the 20 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in CERS (2026Q2)

Manager / securityMarket value% portfolioQoQ
D. E. Shaw & Co., Inc.CUSIP 157085101 · 2026Q2$16M0.01%,
TWO SIGMA INVESTMENTS, LPCUSIP 157085101 · 2026Q2$10.2M0.01%,
CITADEL ADVISORS LLCCUSIP 157085101 · 2026Q2$2.2M0.00%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 157085101 · 2026Q2$2M0.00%,
Point72 Asset Management, L.P.CUSIP 157085101 · 2026Q2$666K0.00%,
MILLENNIUM MANAGEMENT LLCCUSIP 157085101 · 2026Q2$317K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, CERS

CERS against its peers

CERS's operating margin of -3.7% ranks in the 55th percentile of 20 Health Care sub-industry peers, fiscal periods ending between 2025-08-31 and 2026-05-31.

MetricCERSPeer medianPercentilen
Revenue FY234M USD333M USD2620
Gross marginn/a66.0%n/a10
Operating margin-3.7%-9.2%5520
Net margin-6.7%-8.7%6420
Return on equity-24.3%-14.1%2819

Peers (20): CTEV, FLGT, SGHT, ANGO, CCRN, EVH, EHAB, AHCO, SLP, VREX, HSTM, TALK, BVS, RXST, STAA, IRMD, CSTL, PRCT, GDRX, TDOC. Fiscal periods ending between 2025-08-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (CERS: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more CERS signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to CERSand get the insider, 13F, options, and confluence read in one view.

Open the live CERS terminal, free